The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
HUTCHMED and AstraZeneca PLC have initiated a Phase II study of ORPATHYS® (savolitinib), an oral, potent, and highly selective small-molecule ...
read more
The FDA approved the first interchangeable biosimilar product, Mylan’s Semglee (insulin glargine-yfgn). Semglee (insulin glargine-yfgn) is both ...
read more
Minovia Therapeutics, Ltd. and Astellas Pharma Inc. announced a worldwide strategic collaboration and license agreement for the research, development,...
read more
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies ...
read more
Integral Molecular, the industry leader in membrane proteins, announces the launch of GeneCanvas, its proprietary protein engineering platform to ...
read more
Wednesday, August 04, 2021
BioNTech SE and Kite, a Gilead Company announced the closing of the acquisition of the solid tumor neoantigen T cell receptor (TCR) R&D platform and ...
read more
Thursday, August 05, 2021
Kite, a Gilead Company, and Appia Bio, Inc., an early-stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic ...
read more
Certara Inc., a global leader in biosimulation, announced it has signed a definitive agreement to acquire Pinnacle 21 for $310 million in cash and ...
read more
Wednesday, August 11, 2021
Vensica Therapeutics, a clinical stage biopharmaceutical company, announced that it has signed a strategic collaboration agreement with Merz ...
read more
Thursday, August 12, 2021
Cali Biosciences Co., Ltd. , a global biopharmaceutical company focused on the research and development of innovative drugs, announced it has ...
read more
Thursday, August 12, 2021
Researchers at Ben-Gurion University of the Negev (BGU) are developing a novel therapeutic strategy for treating Inflammatory Bowel Diseases (IBD) by ...
read more
Mustang Bio Inc., a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential ...
read more
Biotage is one of the few companies offering a complete solution and ready to go off-the-shelf products for the purification of large-scale lipids, ...
read more
Wednesday, August 18, 2021
Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and LabCentral, a launchpad for early-stage life-...
read more
Navega Therapeutics is developing a different approach with DNA targeting to treat chronic pain and aid in the opioid epidemic via epigenetic ...
read more